4Park S,Kelly R,Kahn JN,et al.Specific substitutions in the echinocandin target fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp.Isolates.Antimicrob.Agents Chemother,2005,49:3264-3273.
5Odds FC,Brown AJ,Gow NA.Antifungal agents:Mechanisms of action.Trends Microbiol,2003,11:272-279.
6Ghannoum MA,Rice LB.Antifungal agents:Mode of action,mechanisms of resistance,and correlation of these mechanisms with bacterial resistance.Clin.Microbiol.Rev,1999,12:501-517.